A Novel Use of Embryonic Gut Organoid Culture to Investigate Duodenal Atresia

jpedsurg.org

The cause of duodenal atresia (DA) is not known. Tandler's “solid cord” hypothesis conflicts with current biological evidence. In humans, a genetic aetiology is supported by the association with Trisomy 21. Interruption of Fgf10 is the strongest genetic link to DA in mice, demonstrating an increased incidence and severity as embryos mature. This project aimed to develop an organoid model to facilitate ex vivo DA research on the FGF10/FGFR2b signalling pathway. We hypothesised that DA morphology represents an evolving spectrum of disease and that Fgf10 knockout organoids would vary in growth pattern compared to wild-type.

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Jul 2024 · 1 min read

In brief

This study develops an embryonic gut organoid model to investigate duodenal atresia pathogenesis, focusing on FGF10/FGFR2b signaling disruption. The research challenges traditional theories and explores how genetic factors, particularly Fgf10 knockout, affect intestinal development patterns in an ex vivo system.

Duodenal atresia etiology remains unclear; Tandler's 'solid cord' hypothesis conflicts with current biological evidence.
Trisomy 21 association supports genetic causation; Fgf10 disruption is the strongest genetic link in mouse models.
Novel embryonic gut organoid model enables ex vivo study of FGF10/FGFR2b signaling in duodenal atresia pathogenesis.
DA morphology may represent an evolving disease spectrum rather than a single fixed defect.
Fgf10 knockout organoids show altered growth patterns, providing a platform for mechanistic DA research.

Written by the GCMD Library team from the article.

Read it at the source ↗